HK1218122A1 - 用於治療炎性疾病和/或免疫疾病的皮質抑素類似物 - Google Patents

用於治療炎性疾病和/或免疫疾病的皮質抑素類似物

Info

Publication number
HK1218122A1
HK1218122A1 HK16106035.6A HK16106035A HK1218122A1 HK 1218122 A1 HK1218122 A1 HK 1218122A1 HK 16106035 A HK16106035 A HK 16106035A HK 1218122 A1 HK1218122 A1 HK 1218122A1
Authority
HK
Hong Kong
Prior art keywords
rti
inflammatory
treatment
immune diseases
statin analogues
Prior art date
Application number
HK16106035.6A
Other languages
English (en)
Inventor
蓬薩提奧維奧爾斯
費爾南德斯卡爾亞多
法雷拉-辛佛洛 約瑟
杜依娜 帕蘭特
Original Assignee
Bcn Peptides Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bcn Peptides Sa filed Critical Bcn Peptides Sa
Publication of HK1218122A1 publication Critical patent/HK1218122A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Birds (AREA)
HK16106035.6A 2013-09-18 2016-05-26 用於治療炎性疾病和/或免疫疾病的皮質抑素類似物 HK1218122A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13382361 2013-09-18
PCT/EP2014/069842 WO2015040089A1 (en) 2013-09-18 2014-09-17 Co rti statin analogues for the treatment of inflammatory and/or immune diseases

Publications (1)

Publication Number Publication Date
HK1218122A1 true HK1218122A1 (zh) 2017-02-03

Family

ID=49880656

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16106035.6A HK1218122A1 (zh) 2013-09-18 2016-05-26 用於治療炎性疾病和/或免疫疾病的皮質抑素類似物

Country Status (24)

Country Link
US (1) US20160185822A1 (zh)
EP (1) EP3046933B1 (zh)
JP (1) JP6989260B2 (zh)
KR (1) KR102285939B1 (zh)
CN (1) CN105579467B (zh)
AU (1) AU2014323131B2 (zh)
BR (1) BR112016005731B1 (zh)
CA (1) CA2921324C (zh)
CL (1) CL2016000392A1 (zh)
DK (1) DK3046933T3 (zh)
ES (1) ES2728319T3 (zh)
HK (1) HK1218122A1 (zh)
HU (1) HUE043206T2 (zh)
IL (1) IL244317B (zh)
LT (1) LT3046933T (zh)
MX (1) MX368373B (zh)
MY (1) MY185593A (zh)
NZ (1) NZ717035A (zh)
PL (1) PL3046933T3 (zh)
PT (1) PT3046933T (zh)
RU (1) RU2678315C2 (zh)
SG (1) SG11201601036UA (zh)
UA (1) UA119148C2 (zh)
WO (1) WO2015040089A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016014760A2 (pt) 2013-12-24 2017-12-12 Harvard College composto, composição farmacêutica, métodos para tratamento de uma condição, para inibir e validar atividade de cinase, para modular o trajeto de b-catenina e o trajeto de tgfb/bmp em uma célula, para modular a atividade de stat1 e de hif-1-alfa em uma célula, para aumentar a expressão de bim e para preparar um composto, mutante, e, proteína
WO2016182932A1 (en) 2015-05-08 2016-11-17 President And Fellows Of Harvard College Cortistatin analogues, syntheses, and uses thereof
EP3316889A4 (en) 2015-07-01 2018-11-14 President and Fellows of Harvard College Cortistatin analogues and syntheses and uses thereof
JP2020526515A (ja) * 2017-07-05 2020-08-31 ウィスコンシン・アルムナイ・リサーチ・ファウンデーションＷｉｓｃｏｎｓｉｎ Ａｌｕｍｎｉ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 遺伝子送達成果を改善する核酸と抗炎症性分子の共送達のためのミネラルコーティングされたマイクロ粒子
CA3089108A1 (en) * 2018-01-31 2019-08-08 Twi Pharmaceuticals, Inc. Topical formulations comprising tofacitinib
WO2019183686A1 (en) 2018-03-29 2019-10-03 Lateral IP Pty Ltd Cyclic peptides and uses thereof
RU2698451C1 (ru) * 2018-07-02 2019-08-27 Павел Александрович Храмов Средство и способ для лечения нейросенсорной тугоухости
ES2780274A1 (es) * 2019-02-15 2020-08-24 Consejo Superior De Investig Científicas (Csic) Cortistatina o un análogo de la misma como agente farmacéuticamente activo en forma latente
JP2023504533A (ja) * 2019-12-05 2023-02-03 ベセエネ ペプチドス エセ．ア． 癌および／または転移の治療のためのペプチド
CN111297876B (zh) * 2020-01-16 2021-04-27 武汉理工大学 一种塞来昔布胶束和和厚朴酚胶束药物联用控释系统及其制备方法
CN113797314B (zh) * 2021-09-29 2023-08-22 山东大学齐鲁医院 Cst多肽在制备股骨头坏死治疗药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660843B1 (en) * 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
EP1040837A3 (en) 1999-02-26 2002-01-02 Erasmus Universiteit Rotterdam Medicaments for the treatment of a choroidal neovascularization (CNV) related disorder
RU2008132149A (ru) 2006-01-05 2010-02-10 Юниверсити Оф Юта Рисерч Фаундейшн (Us) Способы и композиции, имеющие отношение к улучшенным свойствам фармакологических средств, целенаправленно действующих на нервную систему
WO2007082980A1 (es) 2006-01-23 2007-07-26 Consejo Superior De Investigaciones Científicas Composiciones y procedimientos para tratar trastornos inflamatorios e inmunitarios con cortistatina
WO2009043523A2 (en) 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Cortistatin 17 and neuropeptide 1 for use as therapeutic agent
EP2168983A1 (fr) * 2008-09-30 2010-03-31 Ipsen Pharma Nouveaux composés octapeptidiques et leur utilisation thérapeutique
ES2351569B8 (es) * 2009-05-07 2012-06-20 Bcn Peptides S.A. Ligandos peptídicos de receptores de somatostatina.

Also Published As

Publication number Publication date
US20160185822A1 (en) 2016-06-30
MX2016003490A (es) 2016-07-06
IL244317B (en) 2020-06-30
PT3046933T (pt) 2019-05-31
MX368373B (es) 2019-09-27
MY185593A (en) 2021-05-24
ES2728319T3 (es) 2019-10-23
DK3046933T3 (da) 2019-05-13
NZ717035A (en) 2019-11-29
CN105579467A (zh) 2016-05-11
RU2678315C2 (ru) 2019-01-28
HUE043206T2 (hu) 2019-08-28
CL2016000392A1 (es) 2016-11-11
WO2015040089A1 (en) 2015-03-26
IL244317A0 (en) 2016-04-21
AU2014323131A1 (en) 2016-03-10
CA2921324A1 (en) 2015-03-26
JP2016535760A (ja) 2016-11-17
CN105579467B (zh) 2021-03-09
AU2014323131B2 (en) 2018-08-09
EP3046933B1 (en) 2019-02-27
UA119148C2 (uk) 2019-05-10
CA2921324C (en) 2022-11-22
RU2016109410A3 (zh) 2018-05-24
KR20160054512A (ko) 2016-05-16
SG11201601036UA (en) 2016-04-28
RU2016109410A (ru) 2017-10-18
KR102285939B1 (ko) 2021-08-05
PL3046933T3 (pl) 2019-08-30
LT3046933T (lt) 2019-05-27
BR112016005731B1 (pt) 2023-01-17
BR112016005731A2 (zh) 2017-08-01
EP3046933A1 (en) 2016-07-27
JP6989260B2 (ja) 2022-01-05

Similar Documents

Publication Publication Date Title
IL269358B (en) Methods and devices to reduce the chance of injury from the forces of the page
HK1218122A1 (zh) 用於治療炎性疾病和/或免疫疾病的皮質抑素類似物
HRP20181734T1 (hr) Procjena i liječenje poremećaja posredovanih bradikininom
EP3349783C0 (en) COMPOSITIONS AND METHODS ASSOCIATED WITH THE TREATMENT OF DISEASES
IL273090B (en) Methods and preparations for the treatment of cancer
EP2890440A4 (en) DEVICES AND METHOD FOR THE TREATMENT OF VASCULAR DISEASES
EP2968318A4 (en) ANTI-PCSK9 COMPOUNDS AND METHODS FOR TREATING AND / OR PREVENTING CARDIOVASCULAR DISEASES
HK1222398A1 (zh) 治療伯克霍爾德氏菌感染症的組合物及方法
GB201320723D0 (en) Composition and methods of treatment
EP2958936A4 (en) METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE
SG11201509782TA (en) Compositions and methods for the treatment of diabetes and pre-diabetes
GB201404403D0 (en) Compositions and methods relating to the treatment of diseases
HUE046924T2 (hu) Módszerek és készítmények Barth szindróma megelõzésében vagy kezelésében történõ alkalmazásra
HK1220374A1 (zh) 用於治療碳氧血紅蛋白血症的組合物和方法
HK1216721A1 (zh) 治療肝臟疾病或病狀的用途和方法
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
PL3079684T3 (pl) Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna
GB201516303D0 (en) Compositions and methods relating to the treatment of diseases
GB201314015D0 (en) Novel compound useful for the treatment of degenerative and inflammatory diseases
HUP1300454A2 (hu) Daganatos betegségek gyógyítására és megelõzésére alkalmas gyógyászati készítmények, és eljárás azok elõállítására